Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over

Omalizumab for severe persistent allergic asthma. NICE technology appraisal guidance 133 (2007).

Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years. NICE technology appraisal guidance 131 (2007).

Inhaler devices for routine treatment of chronic asthma in older children (aged 5–15 years). NICE technology appraisal guidance 38 (2002).

Inhaler systems (devices) in children under the age of 5 years with chronic asthma. NICE technology appraisal guidance 10 (2000).